Characteristics of warm autoimmune hemolytic anemia and Evans syndrome in adults;Caractéristiques des anémies hémolytiques auto-immunes à anticorps « chauds » et du syndrome d'Evans de l'adulte

Presse Medicale

Volumn 37, Issue 9, 2008, Pages 1309-1318

  Michel, Marc ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID;

AUTOIMMUNE HEMOLYTIC ANEMIA; COOMBS TEST; DIAGNOSTIC TEST; DISEASE ASSOCIATION; HUMAN; IMMUNE DEFICIENCY; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PROGNOSIS; SHORT SURVEY; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOIMMUNE DISEASES; DECISION TREES; ERYTHROCYTES; HUMANS; SYNDROME;

EID: 50649114193     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.01.026     Document Type: Short Survey

References (61)

1. Sokol R.J., Booker D.J., and Stamps R. the pathology of autoimmune haemolytic anemia. J Clin Pathol 45 (1992) 1047-1052
2. nd Ed (2004), Churchill Livingstone, Philadelphia PA
3. Gerhrs B.S., and Friedberg R.C. Autoimmune haemolytic anemia. Am J Hematol 69 (2002) 258-271
4. Rochant H. Anémies Hémolytiques auto-immunes. Encycl Med Chir Hématologie (2000), Elsevier, Paris 13-006-D20
5. Genty I., Michel M., Hermine O., Schaeffer A., Godeau B., and Rochant H. Caractéristiques des anémies hémolytiques auto-immunes de l'adulte : analyse rétrospective d'une série de 83 patients. Rev Med Int 23 (2002) 901-909
6. Gertz M.A. Management of cold haemolytic syndrome. Br J Haematol 138 (2007) 422-429
7. Berentsen S., Ulvestad E., Langholm R., Beiske K., Hjorth-Hansen H., Ghanima W., et al. Primary cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 91 (2006) 460-466
8. Berentsen S., Ulvestad E., Gjertsen B.T., Hjorth-Hansen H., Langholm R., Knutsen H., et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 103 (2004) 2925-2928
9. Semple J.W., and Freedman J. Autoimmune pathogenesis and autoimmune hemolytic anemia. Sem Hematol 42 (2005) 122-130
10. Perry F., Barker R., Mazza G., Day M., Wellq A., Shen C., et al. Autoreactive T cell specificity in autoimmune haemolytic anemia of the NZB mouse. Eur J Immunol 26 (1996) 136-141
11. Fagiolo E., and Toriani-Terenzi C. Th1 and Th2 cytokine modulation by IL10/IL12 imbalance in autoimmune hemolytic anemia. Autoimmunity 35 (2002) 39-44
12. + regulatory T cells control induction of autoimmune haemolytic anemia. Blood 105 (2005) 3746-3747
13. Shenoy S., Mohanakumar T., Chatila T., Tersak J., Duffy B., Wang R., et al. Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias. Clin Immunol 99 (2001) 266-275
14. Kokori S.I., Ioannidis J.P., Voulgarellis M., Tzioufas A.G., and Moutsopoulos H.M. Autoimmune haemolytic anemia in patients with systemic lupus erythematosus. Am J Med 108 (2000) 198-204
15. Borthakur G., O'Brien S., Wierda W.G., Thomas D.A., Cortes J.E., Giles F.J., et al. Immune anemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab. Incidence and predictors. Br J Haematol 136 (2007) 800-805
16. Michel M., Chanet V., Galicier L., Ruivard M., Levy Y., Hermine O., et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine 83 (2004) 254-263
17. Arndt P.A., and Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Sem Hematol 42 (2005) 137-144
18. Johnson S.T., Fueger J.T., and Gottaschall J.L. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia. A new paradigm. Transfusion 47 (2007) 697-702
19. Grimaldi D., Limal N., Noizat-Pirenne F., Janvier D., Godeau B., and Michel M. Anémie hémolytique auto-immune à IgA révélant une infection par le virus C. Rev Med Int 29 2 (2008) 135-138 Epub 2007 Sep 21
20. Hoffman P.C. Immune haemolytic anemia - Selected topics. Hematology. Am Soc Hematol Educ Program (2006) 13-18
21. Hendrick A.M. Autoimmune haemolytic anemia - a high risk for thromboembolism?. Hematology 8 (2003) 53-56
22. Pullakart V., Ngo M., Iqbal S., Espina B., and Liebman H.A. Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anemia at increased risk for venous thromboembolism. Br J Haematol 118 (2002) 1166-1169
23. Petz L.D. Treatment of autoimmune haemolytic anemia. Curr Opin Hematol 8 (2001) 411-416
24. King K.E., and Ness P.M. Treatment of autoimmune haemolytic anemia. Semin Hematol 42 (2005) 131-136
25. Meyer O., Stahl D., Beckhove P., Huhn D., and Salama A. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anemia of warm type. Br J Haematol 98 (1997) 860-862
26. Flores G., Cunningham-Rundles C., Newland A.C., and Bussel J.B. Efficacy of intravenous immunoglobulin in the treatment of autoimmune haemolytic anemia; results in 73 patients. Am J Hematol 44 (1993) 237-242
27. Godeau B., Chevret S., Varet B., Lefrere F., Zini J.M., Bassompierre F., et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 359 (2002) 23-29
28. Pignon J.M., Poirson E., and Rochant H. Danazol in autoimmune haemolytic anemia. Br J Haematol 83 (1993) 343-345
29. Ahn Y.S. Efficacy of danazol in hematologic disorders. Acta Haematol 84 (1990) 122-129
30. Alpeck G., McAneny D., and Weintraub L. Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated diseases. Am J Hematol 61 (1999) 98-102
31. Moyo V.M., Smith D., Brodsky I., Crilley P., Jones R.J., and Brodsky R.A. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood 100 (2002) 704-706
32. Howard J., Hoffbrand A.V., Prentice H.G., and Mehta A. Mycophenolate mofetil for the treatment of refractory autoimmune haemolytic anemia and autoimmune thrombocytopenic purpura. Br J Haematol 117 (2002) 712-715
33. Hershko C., Sonnenblick M., and Ashkenazi J. Control of steroid-resistant autoimmune haemolytic anemia by cyclosporine. Br J Haematol 76 (1990) 436-437
34. Karlsson C., Hansson L., Cesling F., and Lundin J. Treatment of severe refractory haemolytic anemia in B-cell chronic lymphocytic anemia with alemtuzumab (hulmanized CD52 monoclonal antibody). Leukemia 21 (2007) 511-514
35. Brodsky R.A., and Smith B.D. Bone marrow transplantation for autoimmune diseases. Curr Opin Oncol 11 (1999) 83-86
36. Passweg J.R., Rabusin M., Musso M., Beguin Y., Cesaro S., Ehninger G., et al. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 125 (2004) 749-755
37. Cooper N., Stasi R., Cunningham-Rundles S., Feuerstein M.A., Leonard J.P., Amadori S., et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125 (2004) 232-239
38. Quartier P., Brethon B., Philippet P., Landman-Parker J., Le Deist F., and Fisher A. Treatment of childhood autimmune haemolytic anemia with rituximab. Lancet 358 (2001) 1511-1513
39. Zecca M., Nobili B., Ramenghi U., Perrotta S., Amendola G., Rosito P., et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 101 (2003) 3857-3861
40. Shanafelt T.D., Madueme H.L., Wolf R.C., and Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune haemolytic anemia and Evans syndrome. Mayo Clinic Proc 78 (2003) 1340-1346
41. Narat S., Gandla J., Hoffbrand A.V., Hughes R.G., and Mehta A.B. Rituximab in the treatment of refractory autoimmune cytopenias. Haematologica 90 (2005) 1273-1274
42. D'Arena G., Califano C., Annunziata M., Tartarone A., Capalbo S., Villani O., et al. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. Eur J Hematol 79 (2007) 53-58
43. e Congrès français de Médecine Interne. Rev Med Int 27 Suppl. 3 (2006) S322-S323
44. Cabrera JR, Penalver FJ, Millan I, Alvarez-Larran A, Diez-Martin JL, Gallur L et al. Mabthera (rituximab) in the treatment of 34 adult patients with refractory autoimmune hemolytic anemia. Blood (ASH Annual Meeting Abstracts). 2004; 104:Abstract 1619.
45. Evans R.S., Takahashi K., and Duane R.T. Primary thrombocytopenic purpura and acquired haemolytic anemia. Arch Intern Med 87 (1951) 48-65
46. Hauswirth A.W., Skrabs C., Schützinger C., Gaiger A., Lechner K., and Jäger U. Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma 48 (2007) 1139-1149
47. Guitton C., Ledeist F., Tchernia G., and Bader-Meunier B. Auto-immune hemolytic anemia and dyserythropoïesis as the presenting signs of Fas-deficient condition in 3 children. Arch Pediatr 13 (2006) 367-370
48. Teachey D.T., Manno C.S., Azsom K.M., Andrews T., Choi J.K., Greenbaum B.H., et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 105 (2005) 2443-2448
49. Norton A., and Roberts I. Management of Evans syndrome. Br J Haematol 132 (2005) 125-137
50. George J.N. Thrombotic thrombocytopenic purpura. New Eng J Med 345 (2006) 1927-1935
51. George J.N., Woolf S.H., Raskob G.E., Wasser J.S., Aledort L.M., Ballem P.J., et al. Idiopathic thrombocytopenic purpura: A practical guideline developed by explicit methods of the American Society of Hematology. Blood 86 (1996) 3-40
52. Pegels J.G., Helmerhorst F.M., Van Leeuwen E.F., Van de Plas-Van Dalen C., Engelfriet C.P., and Von dem Borne A.E. The Evans syndrome: characterization of the responsible autoantibodies. Br J Hematol 51 (1982) 445-450
53. Mathew P., Chen G., and Wang W. Evans syndrome: results of a national survey. J Pediat Hematol Oncol 19 (1997) 433-437
54. Ng S.C. Evans syndrome: a report of 12 patients. Clinical Lab Hematol 14 (1992) 189-193
55. Michel M, Chanet M, Godeau B, Cirasino L, Emilia G, Zaja F et al. The European Survey on Adult's Evans Syndrome: Analysis of 54 Cases. Blood (ASH Annual Meeting Abstracts). 2005; 106:Abstract 1245.
56. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 (2003) 574-596
57. Khellaf M., Michel M., Schaeffer A., Bierling P., and Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 90 (2005) 829-832
58. Bader-Meunier B., Aladjidi N., Bellman F., Monpoux F., Nelken B., Robert A., et al. Rituximab therapy for childhood Evans syndrome. Haematologica 92 (2007) 1691-1694
59. Emilia G., Messora C., Longo G., and Bertesi M. Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders. Br J Haematol 93 (1996) 341-344
60. Willis F., Marsh J.C.W., Bevan D.H., Killick S.B., Lucas G., Griffiths R., et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Hematol 114 (2001) 891-898
61. Musso M., Porretto F., Crescimanno A., Bondi F., PolizziV, Scalone R., et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 7 (1998) 492-494